Back to Search
Start Over
[Plasmodium falciparum drug resistance and sulfadoxine-pyrimethamine in Africa].
- Source :
-
Bulletin de la Societe de pathologie exotique et de ses filiales [Bull Soc Pathol Exot Filiales] 1989; Vol. 82 (3), pp. 381-4. - Publication Year :
- 1989
-
Abstract
- The sulfadoxine-pyrimethamine combination has not been recommended for the prophylaxis of malaria since 1985 following serious accidents in the USA. However, this drug is worth considering for treatment since it has the advantage over mefloquine of being cheaper, having fewer side effects and it avoids using mefloquine. A study of Plasmodium falciparum resistance to Fansidar should be carried out on cases imported to France to determine an adapted utilisation of this drug. This would be an appreciable advantage for tropical Africa.
- Subjects :
- Adult
Africa ethnology
Animals
Antimalarials
Drug Resistance
Drug Therapy, Combination
Female
France
Humans
Male
Mefloquine
Plasmodium falciparum
Pyrimethamine administration & dosage
Quinolines therapeutic use
Sulfadoxine administration & dosage
Malaria drug therapy
Pyrimethamine therapeutic use
Sulfadoxine therapeutic use
Sulfanilamides therapeutic use
Subjects
Details
- Language :
- French
- Volume :
- 82
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Bulletin de la Societe de pathologie exotique et de ses filiales
- Publication Type :
- Academic Journal
- Accession number :
- 2670291